Gossamer Bio (GOSS) Stock Chart & Stock Price History $1.50 +0.14 (+9.93%) As of 03:27 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Gossamer Bio Stock Price Performance The Gossamer Bio (GOSS) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 27.78%, with a year-to-date return of 65.27%. In the past month, the stock has increased 20.56%, reflecting recent market activity. As of the latest close, Gossamer Bio traded at $1.36 with a market cap of $309.13 million and volume of 696,002 shares. Five years ago, the stock traded at $12.70, representing a 88.23% decrease over that period. At the time, it had a market cap of $868.63 million and a volume of 440,900 shares. Receive GOSS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Gossamer Bio and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+9.93%1 Month Performance+20.56%3 Month Performance+83.91%Year-To-Date Performance+65.27%1 Year Performance+27.78%5 Year Performance-88.23% GOSS Stock Chart for Monday, July, 14, 2025 GOSS Chart by TradingView Gossamer Bio Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/11/2025$1.36$1.36$1.40$1.34696,002 shs$309.13 million07/10/2025$1.36$1.36$1.38$1.301.05 million shs$309.13 million07/09/2025$1.27$1.36+7.09%$1.39$1.271.57 million shs$309.13 million07/08/2025$1.25$1.27+1.60%$1.28$1.221.01 million shs$288.67 million07/07/2025$1.23$1.25+2.04%$1.26$1.201.29 million shs$284.13 million07/04/2025$1.23$1.23$1.25$1.20433,035 shs$278.44 million07/03/2025$1.21$1.23+1.24%$1.25$1.20433,035 shs$278.45 million07/02/2025$1.25$1.21-3.20%$1.28$1.201.17 million shs$275.03 million07/01/2025$1.23$1.25+1.63%$1.33$1.202.37 million shs$284.13 million06/30/2025$1.25$1.23-1.60%$1.31$1.221.98 million shs$279.58 million Get the Latest News and Ratings for GOSS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Gossamer Bio and its competitors with MarketBeat's FREE daily newsletter. 06/27/2025$1.30$1.25-3.85%$1.33$1.2026.05 million shs$284.13 million06/26/2025$1.36$1.30-4.41%$1.37$1.291.25 million shs$295.49 million06/25/2025$1.38$1.36-1.45%$1.39$1.331.30 million shs$309.13 million06/24/2025$1.37$1.38+0.73%$1.41$1.351.09 million shs$313.68 million06/23/2025$1.44$1.37-4.86%$1.42$1.252.21 million shs$311.40 million06/20/2025$1.29$1.44+11.63%$1.44$1.272.26 million shs$327.31 million06/19/2025$1.29$1.29$1.31$1.25691,491 shs$293.22 million06/18/2025$1.24$1.29+4.03%$1.31$1.25691,491 shs$293.22 million06/17/2025$1.28$1.24-3.13%$1.30$1.22916,589 shs$281.85 million06/16/2025$1.24$1.28+3.23%$1.36$1.231.60 million shs$290.95 million06/13/2025$1.27$1.24-2.36%$1.29$1.201.13 million shs$281.85 million Related Companies WVE Stock Chart AMPH Stock Chart GPCR Stock Chart COGT Stock Chart NTLA Stock Chart ARDX Stock Chart AUPH Stock Chart VERV Stock Chart COLL Stock Chart NAGE Stock Chart Receive GOSS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Gossamer Bio and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:GOSS) was last updated on 7/14/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredAn extra $1,000 per month?A little-known Title 15 provision could let you collect instant payouts — $100 to $1,000 — directly from your ...TradeSmith | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredTrump’s biggest move, misreportedThe media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada t...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Gossamer Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Gossamer Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.